Bipolar androgen therapy as platform for personalized medicine in castration-resistant prostate cancer
Abstract Background Bipolar androgen therapy (BAT) with supraphysiologic testosterone (SPT) could be a therapeutic platform to keep the “endocrine interference” going in men with castration resistant prostate cancer CRPC Davis ID., et al(N Engl J Med 38:121-31, 2019), Denmeade SR, Sena LA, Wang H, A...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer
2026-01-01
|
| Cyfres: | Discover Oncology |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1007/s12672-026-04441-2 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|